We are live on
!
Find out more
AG
Aperio Group Portfolio holdings
AUM
$33.8B
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter
Est. Return
+3.3%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
–
AUM
$12.8B
AUM Growth
+$1.1B
(+9.4%)
Cap. Flow
+$840M
Cap. Flow
% of AUM
6.56%
Top 10 Holdings %
Top 10 Hldgs %
12.13%
Holding
2,105
New
79
Increased
1,204
Reduced
715
Closed
98
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Novartis
NVS
|
+$16.2M |
| 2 |
Johnson & Johnson
JNJ
|
+$15.2M |
| 3 |
AT&T
T
|
+$14.3M |
| 4 |
ExxonMobil
XOM
|
+$14.1M |
| 5 |
IBM
IBM
|
+$13.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
|
+$21.6M |
| 2 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$12.3M |
| 3 |
MHFI
MCGRAW-HILL FINANCIAL INC COM
MHFI
|
+$11.1M |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$7.05M |
| 5 |
CAM
CAMERON INTERNATIONAL CORPORATION
CAM
|
+$6.87M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.06% |
| 2 | Healthcare | 14.21% |
| 3 | Technology | 14.12% |
| 4 | Consumer Staples | 9.51% |
| 5 | Industrials | 8.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
PACCAR
PCAR
$70.5B
| $9.83M | 0.08% |
284,270
-3,316
| -1% | -$122K |
|
|
STI
302
DELISTED
SunTrust Banks, Inc.
STI
| $9.83M | 0.08% |
239,206
+19,711
| +9% | +$806K |
|
|
PPL
303
PPL Corp
PPL
$26.9B
| $9.78M | 0.08% |
258,972
-6,340
| -2% | -$241K |
|
304
Valero Energy
VLO
$89.5B
| $9.75M | 0.08% |
191,150
-64,418
| -25% | -$3.65M |
|
305
Intercontinental Exchange
ICE
$87.2B
| $9.71M | 0.08% |
189,580
-3,130
| -2% | -$158K |
|
|
BT
306
DELISTED
BT Group plc (ADR)
BT
| $9.67M | 0.08% |
347,206
-48,869
| -12% | -$1.53M |
|
307
LyondellBasell Industries
LYB
$19.5B
| $9.66M | 0.08% |
129,790
-4,686
| -3% | -$387K |
|
308
Tyson Foods
TSN
$21.5B
| $9.63M | 0.08% |
144,236
+18,645
| +15% | +$1.21M |
|
309
T. Rowe Price
TROW
$25.5B
| $9.55M | 0.07% |
130,861
+5,765
| +5% | +$429K |
|
310
Shinhan Financial Group
SHG
$32.1B
| $9.45M | 0.07% |
288,617
-4,366
| -1% | -$150K |
|
311
Boston Scientific
BSX
$68.4B
| $9.45M | 0.07% |
404,270
+38,322
| +10% | +$829K |
|
312
ING
ING
$92.9B
| $9.44M | 0.07% |
913,810
-158,710
| -15% | -$1.88M |
|
313
Campbell Soup
CPB
$6.85B
| $9.42M | 0.07% |
141,637
+13,470
| +11% | +$845K |
|
314
HDFC Bank
HDB
$123B
| $9.41M | 0.07% |
567,380
-13,232
| -2% | -$211K |
|
315
TC Energy
TRP
$70.1B
| $9.36M | 0.07% |
206,900
+2,261
| +1% | +$93.3K |
|
316
Magna International
MGA
$18.8B
| $9.32M | 0.07% |
265,668
+120,946
| +84% | +$4.87M |
|
317
Norfolk Southern
NSC
$75.4B
| $9.31M | 0.07% |
109,329
+6,656
| +6% | +$566K |
|
318
Agilent Technologies
A
$39.6B
| $9.29M | 0.07% |
209,460
+41,049
| +24% | +$1.77M |
|
319
United Microelectronic
UMC
$42.9B
| $9.29M | 0.07% |
4,668,905
+316,433
| +7% | +$608K |
|
320
Marriott International
MAR
$100B
| $9.22M | 0.07% |
138,666
+23,521
| +20% | +$1.58M |
|
321
Ross Stores
ROST
$80.8B
| $9.09M | 0.07% |
160,412
+5,122
| +3% | +$284K |
|
322
Nasdaq
NDAQ
$53.4B
| $9.07M | 0.07% |
420,879
+21,771
| +5% | +$465K |
|
323
Truist Financial
TFC
$63.9B
| $9.07M | 0.07% |
254,785
+39,063
| +18% | +$1.37M |
|
|
ORAN
324
DELISTED
Orange
ORAN
| $9.06M | 0.07% |
551,862
-37,842
| -6% | -$632K |
|
325
Parker-Hannifin
PH
$120B
| $8.94M | 0.07% |
82,751
+1,158
| +1% | +$130K |
|
Similar funds
OU
CTA
GAM
CCI
SWM
LCM
HCMNY
BII
Aperio Group's Q2 2016 Portfolio in Review
As of Q2 2016, Aperio Group held 2,105 positions worth $12.8B, up 9.4% from $11.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Aperio Group deployed $840M of net new capital in Q2 2016, opening 79 new positions and adding to 1,204 existing holdings. Its largest new stake was S&P Global: 119,543 shares worth $12.8M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Zimmer Biomet, an estimated $6.43M trimmed.
- Aperio Group's largest Q2 2016 buy was S&P Global: 119,543 shares worth $12.8M.
- Aperio Group added most to Novartis in Q2 2016, an estimated $16.2M increase.
- Aperio Group's biggest Q2 2016 reduction was Zimmer Biomet, cutting an estimated $6.43M.
- Aperio Group fully exited TIME WARNER CABLE INC NEW COM STK in Q2 2016, selling an estimated $21.6M.
- Aperio Group's ten largest holdings make up 12% of its $12.8B portfolio in Q2 2016.
- Aperio Group opened 79 new positions and closed 98 in Q2 2016.
- Aperio Group's portfolio value rose 9.4% quarter-over-quarter to $12.8B.
Based on Aperio Group's 13F filing for Q2 2016, filed 12 Aug 2016.